Patents by Inventor Conrad J. Heilman, Jr.

Conrad J. Heilman, Jr. has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Purging of cells using viruses
    Patent number: 7192580
    Abstract: The subject invention relates to viruses that are able to purge (reduce or eliminate) undesirable cells in a mixture of cells. Undesirable cells can include neoplastic cells, cells mediating graft-versus host diseases, and autoimmune cells. The subject invention also relates to the purging of undesirable cells from bone marrow or peripheral blood cell harvests in the treatment of mammals including cancer patients, transplant recipients, and patients with autoimmune disease.
    Type: Grant
    Filed: November 19, 2003
    Date of Patent: March 20, 2007
    Assignees: Wellstat Biologics Corporation, University of Ottawa
    Inventors: Harold L. Atkins, John C. Bell, Conrad J. Heilman, Jr., Brian D. Lichty, Robert M. Lorence, Michael S. Roberts, David F. Stojdl
  • Process for solubilization, purification and characterization of protein from insoluble protein aggregates or complexes and compositions of matter therefrom
    Patent number: 4659568
    Abstract: This invention discloses a novel process for the solubilization, purification and characterization of a protein or proteins from insoluble protein aggregates or complexes. The novel process comprises the use of a dissociating step gradient which can be followed by further purification and concentration. Also disclosed are compositions of matter and vaccines comprising one or more proteins purified according to the novel process of this invention.
    Type: Grant
    Filed: February 27, 1985
    Date of Patent: April 21, 1987
    Assignee: American Cyanamid Company
    Inventor: Conrad J. Heilman, Jr.
  • Test methods employing monoclonal antibodies against Herpes simplex virus types 1 and 2 nucleocapsids proteins
    Patent number: 4430437
    Abstract: The method of producing clinical assays for use of monoclonal antibodies in the diagnosis of Herpes simplex virus (HSV) infections and the differentiation of Herpes Simplex virus types 1 and 2 as a diagnostic kit for differentiating HSV-1 and HSV-2 utilizing clone 1D4 against HSV-1 and clone 3E1 against HSV-2.
    Type: Grant
    Filed: August 27, 1980
    Date of Patent: February 7, 1984
    Assignee: The United States of America as represented by the Department of Health and Human Services
    Inventors: Berge Hampar, Martin Zweig, Harvey Rabin, Conrad J. Heilman, Jr., Ralph F. Hopkins, III, Russell H. Neubauer